Clinico-pathological profile of Bowen’s disease in skin of colour: Experience from a teaching hospital in north India
Keywords:
Bowen’s disease, Carcinoma in situ, Clinico-pathologicalAbstract
Background: Bowen’s disease (BD) is a squamous cell carcinoma in situ, commonly encountered in elderly population with an incidence reported as 15 cases per 100 000 people per year. It is considerably more common in Caucasian skin compared to skin of colour where it has not been studied extensively; the prevalence of BD in skin of colour is now known. Methods: A retrospective study was conducted in the Department of Dermatology, Venereology & Leprology. Hospital records of patients who were seen in the clinic between September 2017 and September 2022 [N= 228,194] were screened, records of patient who underwent biopsy were retrieved [N’= 1431]; eight patients (n=8) with clinical diagnosis of BD, confirmed on histopathology were included in the study Results: The mean age of patients included was 60.37±6.9 years with equal male and female [M:F=1]. The only risk factor identified was prolonged sun exposure seen in half the patients. The mean duration of the lesions at time of presentation was 3.27± 3.21 years. The most common site was trunk (62.5%) followed by lower limb (25%) and head & neck (12.5%). All, except one, had lesion over photo-protected sites. All patients presented with a well-defined plaque; morphological features included pigmentation (75%), scaling (75%), crusting (62.5%), erythema (25%) and ulceration (12.5%). The mean size of the lesion (plaque) at presentation was 5.50 ±3.02 × 5.71 ± 2.81 cm2 Biopsy was characteristic in all cases; features seen were atypia (100%), loss of polarity(100%), acanthosis (87.5%), hyperkeratosis(87.5%), parakeratosis(87.5%), hyperchromatic nucleus(87.5%), pleomorphism(87.5%), dyskeratotic cells (87.5%), mitotic figures(87.5%), “ Windblown appearance” (62.5%), pigment incontinence (62.5%) and dermal invasion (12.5%). The histological variants seen in our study were classical (62.5%), papillated (25%) and irregular (12.5%). Conclusion: We present here our experience of BD seen at our tertiary centre; there are limited case series from India describing BD. More prospective and population-based studies are needed in the future to determine the burden of the disease among Indians Background: Bowen’s disease (BD) is a squamous cell carcinoma in situ, commonly encountered in elderly population with an incidence reported as 15 cases per 100 000 people per year. It is considerably more common in Caucasian skin compared to skin of colour where it has not been studied extensively; the prevalence of BD in skin of colour is now known. Methods: A retrospective study was conducted in the Department of Dermatology, Venereology & Leprology. Hospital records of patients who were seen in the clinic between September 2017 and September 2022 [N= 228,194] were screened, records of patient who underwent biopsy were retrieved [N’= 1431]; eight patients (n=8) with clinical diagnosis of BD, confirmed on histopathology were included in the study Results: The mean age of patients included was 60.37±6.9 years with equal male and female [M:F=1]. The only risk factor identified was prolonged sun exposure seen in half the patients. The mean duration of the lesions at time of presentation was 3.27± 3.21 years. The most common site was trunk (62.5%) followed by lower limb (25%) and head & neck (12.5%). All, except one, had lesion over photo-protected sites. All patients presented with a well-defined plaque; morphological features included pigmentation (75%), scaling (75%), crusting (62.5%), erythema (25%) and ulceration (12.5%). The mean size of the lesion (plaque) at presentation was 5.50 ±3.02 × 5.71 ± 2.81 cm2 Biopsy was characteristic in all cases; features seen were atypia (100%), loss of polarity(100%), acanthosis (87.5%), hyperkeratosis(87.5%), parakeratosis(87.5%), hyperchromatic nucleus(87.5%), pleomorphism(87.5%), dyskeratotic cells (87.5%), mitotic figures(87.5%), “ Windblown appearance” (62.5%), pigment incontinence (62.5%) and dermal invasion (12.5%). The histological variants seen in our study were classical (62.5%), papillated (25%) and irregular (12.5%). Conclusion: We present here our experience of BD seen at our tertiary centre; there are limited case series from India describing BD. More prospective and population-based studies are needed in the future to determine the burden of the disease among IndiansReferences
Bowen JT. Precancerous dermatoses: A study of 2 cases of chronic atypical epithelial proliferation. J Cutan Dis. 1912; 0:241-255
Morton CA, Birnie AJ, Eedy DJ. British Association of Dermatologists’ guidelines for the management of squamous cell carcinoma in situ (Bowen’s disease) 2014. Br J Dermatol. 2014; 170(2):245–260. DOI: 10.1111/bjd.12766
Arlette JP, Trotter MJ. Squamous cell carcinoma in situ of the skin: history, presentation, biology and treatment. Australas J Dermatol. 2004, 45(1):1–11. DOI: 10.1111/j.1440-0960.2004.00025.x
Murao K, Yoshioka R, Kubo Y. Human papillomavirus infection in Bowen disease: negative p53 expression, not p16(INK4a) overexpression, is correlated with human papillomavirusassociated Bowen disease. J Dermatol. 2014; 41(10):878–884. DOI: 10.1111/1346-8138.12613
Shimizu A, Tamura A, Abe M, Amano H, Motegi S, Nakatani Y, Hoshino H, Ishikawa O. Human papillomavirus type 56- associated Bowen disease. Br J Dermatol, 2012, 167(5):1161–1164. https://doi.org/10.1111/j.1365-2133.2012.11071.x
Kang S, Amagai M, Bruckner AL et al., Fitzpatrick's Dermatology in General Medicine. 9th ed. New York: Mcgraw-Hill; 2019. pp. 1857–1883.
Gahalaut P, Rastogi MK, Mishra N, Chauhan S. Multiple Pigmented Bowen's Disease: A Diagnostic and Therapeutic Dilemma. Case Rep Oncol Med 2012; 2012: 342030. DOI: 10.1155/2012/342030
Reizner GT, Chuang TY, Elpern DJ, Stone JL, Farmer ER. Bowen's disease (squamous cell carcinoma in situ) in Kauai, Hawaii. A population-based incidence report. J Am Acad Dermatol. 1994;31:596–600. DOI: 10.1016/s0190-9622(94)70222-5
Thestrup-Pedersen K, Ravnborg L, Reymann F. A description of disease in 617 patients. Acta Derm Venereol 1988;68: 236-239. https://europepmc.org/article/med/2455417
Cox NH. Body site distribution of Bowen’s disease. Br J Dermatol 1994;130:714-716. DOI: 10.1111/j.1365-2133.1994.tb03407.x
Kossard S, Rosen R. Cutaneous Bowen’s disease: An analysis of 1001 cases according to age, sex and site. J Am Acad Dermatol 1992;27:406-410. DOI: 10.1016/0190-9622(92)70208-w
Swaroop MR, Manas SN, Basavaraj HB et. al. Bowen’s disease: a series of cases. Int J Health Sci Res. 2015; 5(2):488-491. https://www.ijhsr.org/IJHSR_Vol.5_Issue.2_Feb2015/78.pdf
Nakai K, Yoneda K, Moriue J, Moriue T, Kubota Y. Hypokeratosis of multiple Bowen’s disease of the palms. Dermatol Sin, 2016, Sep 2, doi:10.1016/j.dsi.2016.08.001.
Saito T, Uchi H, Moroi Y, Kiryu H, Furue M. Subungual Bowen disease revealed by longitudinal melanonychia. J Am Acad Dermatol, 2012, 67(5):e240–241. DOI: 10.1016/j.jaad.2012.03.031.